Access cutting-edge cystic fibrosis diabetes treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access cystic fibrosis diabetes specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis diabetes treatment provided free
This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to us
Sponsor: Jaeb Center for Health Research
Check if you qualify for this cystic fibrosis diabetes clinical trial in Boston, MA
If you're searching for cystic fibrosis diabetes treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.